Bulletin
Investor Alert

New York Markets Open in:

press release

May 4, 2020, 4:44 p.m. EDT

CymaBay Therapeutics to Report First Quarter 2020 Financial Results on Monday, May 11

NEWARK, May 04, 2020 (GLOBE NEWSWIRE via COMTEX) -- NEWARK, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. /zigman2/quotes/201917619/composite CBAY -4.32% , a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that it will host a conference call and live audio webcast on Monday, May 11, 2020 at 4:30 p.m. Eastern Time to discuss financial results for the first quarter ended March 31, 2020 and to provide a business update.

Conference Call Details
To access the live conference call, please dial 855-327-6837 from the U.S. and Canada, or 631-891-4304 internationally, Conference ID# 10009543. To access the live and subsequently archived webcast of the conference call, go to the Investors section of the company's website at http://ir.cymabay.com/events .

About CymaBay

CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet medical need.

For additional information about CymaBay visit www.cymabay.com .

Contact:
Sloane & Company
Dan Zacchei / Joe Germani, 212-486-9500
Dzacchei@sloanepr.com / JGermani@sloanepr.com

(C) Copyright 2020 GlobeNewswire, Inc. All rights reserved.

/zigman2/quotes/201917619/composite
US : U.S.: Nasdaq
$ 3.32
-0.15 -4.32%
Volume: 778,770
July 13, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$239.02 million
Rev. per Employee
N/A
loading...

Link to MarketWatch's Slice.